Egalet Revenue and Competitors

Wayne, PA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Egalet's estimated annual revenue is currently $2.6M per year.(i)
  • Egalet's estimated revenue per employee is $201,000

Employee Data

  • Egalet has 13 Employees.(i)
  • Egalet grew their employee count by 0% last year.

Egalet's People

NameTitleEmail/Phone
1
Territory ManagerReveal Email/Phone
2
EVP/COOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$43.2M2156%N/AN/A
#2
$81.8M40710%N/AN/A
#3
$11.7M580%N/AN/A
#4
$1011.8M5034-9%N/AN/A
#5
$44.8M2231%N/AN/A
#6
$13.1M655%N/AN/A
#7
$16.5M8241%N/AN/A
#8
$17.3M86-5%N/AN/A
#9
$67.9M33823%N/AN/A
#10
$14.9M747%N/AN/A
Add Company

What Is Egalet?

Egalet, a fully integrated specialty pharmaceutical company, is focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions. Egalet has three approved products: ARYMO™ ER (morphine sulfate) extended-release tablets for oral use only –CII, developed using Egalet's proprietary Guardian™ Technology, OXAYDO® (oxycodone HCI, USP) tablets for oral use only –CII and SPRIX® (ketorolac tromethamine) Nasal Spray. Using Guardian Technology Egalet is developing a pipeline of clinical-stage, product candidates including Egalet-002, an abuse-deterrent, extended-release, oral oxycodone formulation for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Guardian Technology can be applied broadly across different classes of pharmaceutical products and can be used to develop combination products that include multiple active pharmaceutical ingredients with similar or different release profiles. For full prescribing information on ARYMO ER, including the boxed warning and medication guide, please visit arymoer.com. For full prescribing information on SPRIX, including the boxed warning and medication guide, please visit sprix.com. For full prescribing information on OXAYDO, including the boxed warning, please visit oxaydo.com. For additional information on Egalet, please visit egalet.com.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2.6M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Egalet News

2022-04-19 - Opioids Drug Market Size, Outlook And Forecast | Purdue ...

Purdue Pharma, J&J, Teva, Mylan, Depomed, INSYS, Endo, Pfizer, Hikma, Mallinckrodt, Pernix, Egalet, Vistapharm. This comprehensive Opioids Drug Market...

2022-04-17 - Opioids Drugs Market Size, Outlook And Forecast | Purdue ...

Purdue Pharma, J&J, Teva, Mylan, Depomed, INSYS, Endo, Pfizer, Hikma, Mallinckrodt, Pernix, Egalet, Vistapharm.

2022-04-17 - Opioids Agonist Drugs Market Size, Scope And Forecast ...

... Janssen Pharmaceuticals, Inc, Sanofi, Sun Pharmaceuticals, Mallinckrodt Pharmaceuticals, Egalet Corporation, Endo Pharmaceuticals Inc.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M138%N/A
#2
$1.8M140%N/A
#3
$2M14-7%N/A
#4
$3.5M14100%N/A
#5
$2.8M14-71%N/A